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ABSTRACT
Angiomyolipoma (AML) is a hamartomatous growth that usually affects the kidney. One third of patients with AML 
present with manifestations of tuberous sclerosis. Oral AML is rare with only 6 cases reported in the English-language 
literature. In the present case, AML was located in the upper lip of a 43 year-old woman. Clinically, it presented as a 
firm nodule, well circumscribed and measuring 1x2 cm. It was surgically excised. Histopathological analysis showed a 
lesion composed of an admixture of smooth muscle cells, blood vessels, and adipose tissue. The immunohistochemical 
study revealed positivity for vimentin, smooth muscle actin, pan specific muscle actin and desmin. CD68, CD34 and 
mast cell antibodies showed focal immunoreactivity. S100 protein, Ki-67, and HMB-45 were negative. Based on these 
histological and immunohistochemical features the diagnosis was of oral AML. No recurrence was observed after 2 
years of follow-up.
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RESUMEN
El angiomiolipoma (AML) es un crecimiento tumoral hamartomatoso que usualmente afecta el riñón. Un tercio de 
los pacientes con AML cursan con manifestaciones de esclerosis tuberosa. El AML de la cavidad oral es raro y hasta 
la fecha  se han reportado 6 casos en la literatura de habla inglesa.  El presente caso constituye un AML localizado en 
el labio superior en una paciente de 43 años de edad.  Clínicamente era un nódulo de 1x2cm., firme y bien circunscrito. 
Fue removido quirúrgicamente. El estudio histológico reveló una lesión compuesta por una mezcla de músculo liso, 
vasos sanguíneos y tejido adiposo. El análisis inmunohistoquímico reveló positividad para vimentina, actina alfa de 
músculo liso, pan-actina músculo específico y desmina. CD68, CD34 y anticuerpos anti-mastocitos mostraron inmu-
noreactividad focal. Proteína S-100, Ki-67 y HMB-45 fueron negativos. Basados en estas características histológicas e 
inmunohistoquímicas se estableció el diagnóstico de AML oral. No se ha observado recurrencia 2 años después de su 
remoción.
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INTRODUCTION
Angiomyolipoma (AML) is a tumour that commonly affects 
the kidney (1), and one third of patients present symptoms 
of tuberous sclerosis (TS). Extrarenal AML is uncommon 
and it is usually not associated with TS (2).  Among the 
extrarenal sites, the liver is the most frequently involved, 
however, some cases have been reported in other sites such 
as the mediastinum, abdominal wall, heart, spermatic cord, 
vaginal wall, fallopian tube, oral cavity, oropharynx, nasal 
cavity, lung, spinal cord, penis, retroperitonium, salivary 
gland and skin (1-6). According to the English-language 
literature, only 6 cases of oral AML have been reported. 
The histological diagnosis is based on the triad: mature 
adipose tissue, convoluted thick-walled blood vessels and 
irregularly arranged sheets, and interlacing fascicles of 
smooth muscle (4). Extrarenal AML, despite the histological 
similarities, differs in several ways from renal AML. AML 
of the kidney is composed of smooth muscle cells, blood 
vessels and mature fat cell, with a variable proportion of 
each component in individual tumours (1,5), but they can 
be invasive and may recur.  Extrarenal AML is usually well 
circumscribed, easily resected, and HMB-45 (melanocyte 
marker) negative. However, renal AML associated with TS 
is positive for HMB-45. The purpose of the present report is 
to describe the first case of oral AML located in the upper 




A 43-year-old Guatemalan woman was referred to the 
dental clinic for evaluation of a painful mass on the upper 
lip, crossing the midline. According to the patient the lesion 
had been present for 6 years. On palpation, it was of firm 
consistency, well circumscribed with overlying normal 
appearing mucosa. It measured 2 cm at its greatest dimen-
sion. The medical history was unremarkable. Under local 
anesthesia, the lesion was easily resected. Microscopically, it 
showed a well-demarcated lesion surrounded by an incom-
plete capsule. The tissue was composed of an admixture of 
smooth muscle cell, blood vessels, and adipose tissue (Fig.1). 
Smooth muscle cells were of different sizes and arranged 
around vascular spaces, with the vessel walls showing foci 
of hyalinization. The following antibodies were applied in 
order to diagnose our case: Alpha smooth muscle actin 
(clone 1A4, dilution 1: 400, Dako A/S, Glostrup, Den-
mark), Pan specific muscle actin (clone HHF-35, dilution 
1:800, Dako A/S, Glostrup, Denmark),  Vimentin (clone 
Vim 3B4, dilution 1: 400, Dako A/S, Glostrup, Denmark), 
Desmin (clone D33, dilution 1:1000, Dako A/S, Glostrup, 
Denmark), CD34 (clone QBEnd10, dilution 1:50, Dako A/S, 
Glostrup, Denmark), Ki-67 (clone Ki-S5, dilution 1:200, 
Dako A/S, Glostrup, Denmark), S-100 protein (dilution 
1: 10000, Dako A/S, Glostrup, Denmark), CD68 (clone 
PGM1, dilution 1:400, Dako A/S, Glostrup, Denmark), 
Mast cell antibody (clone AA1, dilution 1: 10000, Dako 
A/S, Glostrup, Denmark) and HMB-45 (dilution 1:200, 
Dako A/S, Glostrup, Denmark). 
Fig. 4. Oral AML showing intense positivity for 
desmin (Immunoperoxidase, original magnifica-
tion, x100). 
Fig. 1.  AML showing the intimate mixture of smoo-
th muscle, blood vessels and mature fat cells (H&E, 
original magnification, x50).
Fig. 2. Immunohistochemistry exhibiting positivity 
for smooth muscle actin antibody in smooth muscle 
and vascular structures of the AML (Immunoperoxi-
dase, original magnification, x100).
Fig. 3. High-power view displaying intense immu-
noreactivity for pan specific muscle actin (HHF-35) 
(Immunoperoxidase, original magnification, x200).
E103
Med Oral Patol Oral Cir Bucal 2007;12:E101-4.                                                                            � Angiomyolipoma of the upper lip                                                         Med Oral Patol Oral Cir Bucal 2007;12:E101-4.                                                                         � Angiomyolipoma of the upper lip
For the immunohistochemical reaction we used citrate buffer 
pH 6,0 for antigen recuperation and 3% hydrogen peroxidase 
for endogen peroxidase inactivation. For detection of the 
primary antibodies, we used secondary antibody conjugated 
with streptavidin-biotin-peroxidase (Strep ABComplex/
HRP Duet, Mouse/Rabbit, Dako A/S, Glostrup, Denmark), 
which were revealed using diaminobenzidine and counters-
tained with hematoxylin of Carazzi. The immunoexpression 
was considered positive or negative. Immunohistochemical 
findings showed intense immunoreactivity for vimentin, 
alpha smooth muscle actin, pan muscle actin and desmin 
(Figs. 2-4). CD68, CD34 and mast cell antibodies showed 
focal positivity. S100 protein, Ki-67 and HMB-45 were ne-
gative. Based on these findings the diagnosis of oral AML 
was confirmed. Renal ultrasonography was normal and 
the patient had no family history of TS. After 2 years of 
follow-up, no recurrence has been observed.
 
DISCUSSION
Stout (1953) (7) proposed the term benign mesenchymoma 
to indicate a benign lesion composed of two or more me-
senchymal tissue components.  Accordingly, AML could be 
considered a type of benign mesenchymoma. 
As discussed by Shimizu et al (8) and Val Bernal and Mira 
(1996) (9), the term angiomyolipoma is preferred for this 
entity since it provides more information regarding the 
morphological nature of the lesion (2).
 TS is a hereditary syndrome transmissible through genetic 
mutation involving chromosomes 9 or 16, but it is also 
recognized in a sporadic form that probably occurs due to 
spontaneous mutation. Patients exhibit angiofibromatosis, 
epilepsy or mental retardation, cutaneous lesions such as 
hypomelanotic spots and angiofibromas (“adenoma seba-
ceum”). TS is associated with intracranial and extracranial 
tumours, among which renal AMLs. In contrast, this asso-
ciation has been rarely reported in extrarenal AML (2). The 
current case did not present intra or extraoral findings of 
the TS and the renal ultrasonography was normal.
Six cases of oral AML have been previously reported in the 
English-language literature (Table 1). However, one of these 
cases, reported by Ide et al (4) lacked the classic features of 
oral AML, according to these authors, who suggested the 
term angiomyolipomatous hamartoma.  In our opinion, 
the lesion contained the 3 types of mesenchymal tissues 
that confirmed AML, so we decided to classify it as AML 
in accordance with the reported findings. 
#Angiomyolipomatous hamartoma; * Present report; F: female; M: male; Na: not available.
Table 1. Clinical data of seven oral AML reported in the English-language literature.






39 M Hard 
palate 
1 cm 2 years Surgical 
excision 
No 1 year 
62 F Hard 
palate 





69 F Lower lip 1 cm 14 years Surgical 
excision 
No 2 years 
Ide et al. 1998 # 60 F Border of 
tongue
0,7 cm 1 year Surgical 
excision 
No 7 years 
Piattelli et al.
2001
43 M Hard 
palate 









0,6 cm Na Na Yes 1 year 
Silva et al.* 43 F Upper lip 2 cm 6 years surgical 
excision 
No 1 year 
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Oral sites affected by AML included the hard palate (1,3,10), 
lower lip (10), lateral border of the tongue  (4) and buccal 
mucosa (11). These lesions affected adults between the 
fourth and sixth decade of life and showed predilection for 
women. The mean size of the tumour was 1,0 cm (0,6 cm 
– 2 cm). The mean duration of the oral AML was of 8.3 
years (10 months – 14 years). These clinical features are 
similar to our case, except for the location, being the first 
case described affecting the upper lip. Recently, López et 
al. (11) reported one case of oral AML associated with TS, 
which affected the lower lip and buccal mucosa. According 
to these authors oral AML associated with TS seems also 
to be a single presentation.
Renal AML is a distinctive tumour composed of smooth 
muscle cells, vessels and mature fat cells, with the proportion 
of each component varying in individual tumours (5).  Liver 
and renal AMLs typically show epithelioid cells, which are 
positive for anti-HMB 45 antibody in many cases, but HMB-
45 positivity can be weaker or absent in spindle cells (2). The 
present case was positive for vimentin, alpha smooth muscle 
actin, pan muscle actin and desmin, which are usually ex-
pressed in mesenchymal tumors with muscle differentiation. 
It was negative for S-100 protein, and showed some cells 
with epithelioid appearance; however they were negative for 
HMB-45. Our results agree with the positivity described for 
alpha smooth muscle actin in oral AML (1-2,4-6,10) and 
negativity for HMB-45 (1-2,4-6). Interestingly, our case was 
positive for desmin, which not occurred in the cases reported 
by Ide et al. (4) and Yamamoto et al. (10).
The differential diagnosis includes angiolipoma and angio-
leiomyoma. Angiolipoma is composed of blood vessels and 
fat tissue, and does not present smooth muscle proliferation. 
To differentiate angiomyolipoma from angiolipoma, it is 
necessary to demonstrate smooth muscle bundles. Angio-
leiomyoma may resemble AML, because both show abun-
dant blood vessels and smooth muscle fibres. Furthermore, 
there are some angioleiomyomas reported in the literature 
that exhibited mature fat cells (10). The histopathology 
characteristics found in our case, excluded the differential 
diagnosis previously mentioned.
In summary, we report an additional case of oral AML 
located in the upper lip. This case and the English-language 
literature data confirms that oral AMLs are uncommon, 
solitary, noninvasive, and easily resected lesions, rarely 
associated with TS, and negative for HMB-45. 
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